+2 more ↓
81%
Finnrick rating
#4 of 57 Semaglutide vendors
13 of 15 classifiable tests passed
natural 87%
methodology · Purity focus
Finnrick analysis · Semaglutide

Peptide Sciences semaglutide has caveats despite strong multi-lab purity evidence: two near-threshold purity misses and repeated underfill, including -28%. The latest public sample passed but lacked a batch ID.

methodology →
vendor intelligence report
Vendor Intelligence Report: Peptide Sciences

The dossier follows a post-shutdown P-Sciences lookalike through WHOIS, a Fort Lauderdale mail-drop, Florida registry searches and crypto payment rails. It also separates stale coupon funnels, QR Peptides and peptides.gg from the original brand.

27 pages4 risk factors assessed3 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$1.30
91%
6
2
Semaglutideselected
$28.33
81%
15
3
Ipamorelin
$8.80
78%
9
4
PT-141
$5.50
78%
6
5
Tirzepatide
$6.67
68%
17
6
BPC-157
$9.50
60%
13
7
Retatrutide
$17.92
56%
41
8
Melanotan II
$4.67
55%
10
9
Tesamorelin
$10.42
38%
4
10
CJC-1295
$11.20
17%
11
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%17 Dec 2024: 87%13 Feb 2025: 73%13 Feb 2025: 68%14 Feb 2025: 76%19 Feb 2025: 81%28 Mar 2025: 82%28 Mar 2025: 83%28 Mar 2025: 84%28 Mar 2025: 86%5 May 2025: 84%5 May 2025: 79%5 May 2025: 80%5 May 2025: 81%22 Jul 2025: 81%1 Mar 2026: 82%9 Aug 2026: current 81%87%81%81%Dec 24Aug 26
Showing Semaglutide tests only
Peptide Sciences Semaglutide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
1 Mar 2026Pass
Tested
lab nameView COA
22 Jul 2025Pass
Tested
lab nameView COA
5 May 2025Pass
Tested
lab nameView COA
5 May 2025Pass
Tested
lab nameView COA
5 May 2025Fail
Tested
lab nameView COA
5 May 2025Pass
Tested
lab nameView COA
28 Mar 2025Pass
Tested
lab nameView COA
28 Mar 2025Pass
Tested
lab nameView COA
28 Mar 2025Pass
Tested
lab nameView COA
28 Mar 2025Pass
Tested
lab nameView COA
1-10 of 15

About Peptide Sciences test results from Finnrick

Peptide Sciences is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 10 peptides and 132 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Peptide Sciences peptides in this dataset are Semaglutide (15 tests), Retatrutide (41 tests) and Melanotan II (10 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 132 recent tests.

Corrections
No corrections.